Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Enrollment goal reached for phase III Xibrom trial

Dec. 22, 2003

Oxigene expands ophthalmology R&D program

Dec. 17, 2003

Inhibition of factor 5A1 reduces apoptosis caused by TNF-alpha

Dec. 16, 2003

National Eye Institute supports Genvec PEDF work through SBIR grants

Dec. 15, 2003

Allergan and Inspire sign copromotion agreement for Elestat

Dec. 11, 2003

Clinical trials confirm the good safety profile of anecorvate acetate

Dec. 3, 2003

New calpain inhibitors, their preparation and use, reported by Senju team

Nov. 26, 2003

DES may facilitate repair of damaged nerve cells

Nov. 19, 2003

Two phase III studies for Retaane planned for January

Nov. 18, 2003

Inhibition of glutamate carboxypeptidase II as a novel approach to diabetic retinopathy

Nov. 14, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...